Contents hide 1 Non-small Cell Lung Cancer 2 Dosage Modifications 2.1 Dosage modifications for adverse reactions Lorlatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) in adults that has spread to other parts of the body. Lorlatinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. Non-small Cell Lung Cancer Indicated for metastatic non-small cell lung cancer (NSCLC) in patients whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test 100 mg PO qDay with or without … Continue reading LORLADX 100 (Lorlatinib)